Bioavailability Study of Fexofenadine HCl New Formulation Tablet

NCT06284902 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Fexofenadine HCl Coated tablet
DRUG: Fexofenadine HCl New Formulation Tablet

Sponsor

Opella Healthcare Group SAS, a Sanofi Company